MDWD vs AMRO Comparison

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid, is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Amaero Inc specializes in manufacturing high-performance powders and near-net-shape components using additive manufacturing and HIP technologies, ensuring precision, material integrity, and reduced times for critical applications. It serves in industries of Aerospace, Defense, Energy, Oil & Gas, and Others. The group leverages cutting-edge gas atomization and hot isostatic pressing (HIP) technologies to create high-performance components that reduce porosity and improve material integrity. Its focus is on reshoring critical materials production and defense manufacturing, offering high-value refractory, specialty, and titanium alloyed powders.